Jinling Pharmaceutical announced that Nanjing Jingu Hospital Management Co., Ltd., a holding subsidiary of the company, had previously entered bankruptcy and liquidation proceedings. The Nanjing Xuanwu District People's Court ruled that the Golden Drum Company will be restructured from September 20, 2026. The company stated that the matter will not have a significant impact on overall business development, production and operation, and financial conditions and operating results for the current period; if the restructuring fails, there is a risk that Jingu will be declared bankrupt and liquidated.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.